Skip to main content
. Author manuscript; available in PMC: 2019 Apr 4.
Published in final edited form as: Clin Gastroenterol Hepatol. 2017 Jun 8;15(11):1698–1707.e7. doi: 10.1016/j.cgh.2017.05.048

Table 1.

Baseline Demographic, Clinical, and Histologic Characteristics of All Subjects Who Underwent FFED

Variable N (%)
P value
Patients completing the FFED
n = 78
Responders
n = 50 (64%)
Nonresponders
n = 28 (36%)
Age, y, mean SD  9.01 ± 4.88 9.21 ± 4.9  8.66 ± 4.92  .6376
Gender, n (%)
  Male  52 (66.67)    29 (58)    23 (82.14)  .0300a
  Female  26 (33.33)    21 (42)     5 (17.86)
White, n (%)  65 (83.33)    39 (78)    26 (92.86)  .1194
Presenting symptoms, n (%)
  Abdominal pain  39 (50)    25 (50)    14 (50)  .9999
  Slow eating  33 (42.31)    21 (42)    12 (42.86)  .9414
  Early satiety  32 (41.03)    21 (42)    11 (39.29)  .8152
  Dysphagia  27 (34.62)    15 (30)    12 (42.86)  .2522
  Vomiting  24 (30.77)    15 (30)     9 (32.14)  .8441
  Poor appetite  25 (32.05)    16 (32)     9 (32.14)  .9897
  Feeding difficulties  21 (26.92)    12 (24)     9 (32.14)  .4367
  Regurgitation  20 (25.64)    12 (24)     8 (28.57)  .6574
  Poor weight gain  18 (23.08)    12 (24)     6 (21.43)  .7960
  Food impaction  19 (24.36)    14 (28)     5 (17.86)  .3168
  Nausea  18 (23.08)     9 (18)     9 (32.14)  .1550
  Pocketing food/spitting after chewing  18 (23.08)    12 (24)     6 (21.43)  .7960
  Gagging/choking  18 (23.08)    13 (26)     5 (17.86)  .4129
  Heartburn  10 (12.82)     5 (10)     5 (17.86)  .4814
  Chest pain  12 (15.38)     6 (12)     6 (21.43)  .3319
  Odynophagia   8 (10.26)     4 (8)     4 (14.29)  .4478
  Nocturnal awakening caused by symptoms   8 (10.26)     5 (10)     3 (10.71)  .9999
Atopy, n (%)
  Eczema  32 (41.03)    20 (40)    12 (42.86)  .8056
  IgE-mediated food allergy (n = 77)  24 (31.17)    12 (24.49)    12 (42.86)  .0942a
  Asthma  22 (28.21)    18 (36)     4 (14.29)  .0409
  Allergic conjunctivitis  14 (17.95)    10 (20)     4 (14.29)  .5281
  Allergic rhinitis  46 (58.97)    29 (58)    17 (60.71)  .8152
Family history (n = 77) , n (%)
  Rhinitis  55 (71.43)    32 (65.31)    23 (82.14)  .1157
  Asthma  40 (51.95)    22 (44.9)    18 (64.29)  .1014
  GERD  41 (53.25)    26 (53.06)    15 (53.57)  .9656
  Food allergy  34 (44.16)    15 (30.61)    19 (67.86)  .0015a
  Eczema  31 (40.26)    18 (36.73)    13 (46.43)  .4041
  Hiatal hernia  17 (22.08)     9 (18.37)     8 (28.57)  .2990
  EoE  11 (14.29)     6 (12.24)     5 (17.86)  .5157
  Stricture   9 (11.69)     6 (12.24)     3 (10.71)  .9999
  Celiac   4 (5.19)     4 (8.16)     0 (0)  .2903
  Recurrent vomiting   4 (5.19)     1 (2.04)     3 (10.71)  .1337
Common food allergens on skin prick test, n (%)
  Egg (n = 54)  18 (33.33)    10 (27.03)     8 (47.06)  .1470
  Milk (n = 55)  13 (23.64)     9 (24.32)     4 (22.22)  .9999
  Soy (n = 54)  21 (38.89)    12 (33.33)     9 (50)  .2363
  Wheat (n = 53)  11 (20.75)     8 (22.22)     3 (17.65)  .9999
Food sensitization on serum-specific IgE test, n (%)
  Egg (n = 53)  24 (45.28)    11 (29.73)    13 (81.25)  .0005a
  Milk (n = 56)  31 (55.36)    18 (47.37)    13 (72.22)  .0806a
  Soy (n = 55)  21 (38.18)    10 (26.32)    11 (64.71)  .0068a
  Wheat (n = 53)  24 (45.28)    13 (34.21)    11 (73.33)  .0100
Endoscopy visual findings, n (%)
  Furrows (n = 76)  56 (73.68)    34 (70.83)    22 (78.57)  .4599
  Edema (n = 75)  53 (70.67)    32 (66.67)    21 (77.78)  .3104
  Exudates (n = 76)  41 (53.95)    24 (50)    17 (60.71)  .3660
  Rings (n = 76)   9 (11.84)     5 (10.42)     4 (14.29)  .7178
  Strictures (n = 76)   1 (1.32)     0 (0)     1 (3.57)  .3684
Baseline peak eosinophil count, median (IQR)  60 (40–100)  52.5 (40–85)    80 (48–100)  .1211
Posttreatment peak eosinophil count, median (IQR)   8 (3–40)     5 (1–8)    51 (35.5–90) <.0001a

NOTE. Chi-square and Fisher exact tests were used to assess differences in response groups for categorical variables. A 2-sample t-test was used to compare age between groups, and the nonparametric Wilcoxon rank sum test was used to compare baseline peak EOS and posttreatment EOS. EoE, eosinophilic esophagitis; FFED, 4-food elimination diet; GERD, gastroesophageal reflux disease; IQR, interquartile range.

a

P values < .05 were considered statistically significant.

HHS Vulnerability Disclosure